Immune Checkpoint Inhibitors: A Promising Choice for Endometrial Cancer Patients?

Although around 80% of endometrial cancers are diagnosed at early stages and present with a 5-year survival rate exceeding 95%, patients with advanced and recurrent disease show a poor prognosis and low response rates to standard chemotherapy. In the era of targeted therapy, the great advances in th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Med
Main Authors: Musacchio, Lucia, Boccia, Serena Maria, Caruso, Giuseppe, Santangelo, Giusi, Fischetti, Margherita, Tomao, Federica, Perniola, Giorgia, Palaia, Innocenza, Muzii, Ludovico, Pignata, Sandro, Benedetti Panici, Pierluigi, Di Donato, Violante
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7356971/
https://ncbi.nlm.nih.gov/pubmed/32503218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9061721
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados